What are common topical ointments used in orthopedics for musculoskeletal pain or inflammation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Topical Ointments in Orthopedics

Topical NSAIDs, particularly diclofenac gel and ketoprofen gel, are the first-line topical pharmacological treatments for musculoskeletal pain in orthopedics, with topical capsaicin serving as an adjunct for chronic conditions like osteoarthritis. 1, 2

First-Line Topical Agents

Topical NSAIDs (Primary Choice)

Topical NSAIDs are preferred over systemic treatments for mild to moderate musculoskeletal pain, especially when only a few joints are affected, due to their favorable safety profile and efficacy. 1

Diclofenac Formulations

  • Diclofenac gel (Emulgel®) is the most effective topical NSAID for acute musculoskeletal injuries (strains, sprains), with 78% of patients achieving at least 50% pain relief versus 20% with placebo at 7 days (NNT 1.8) 3, 4
  • For chronic knee osteoarthritis, apply 40 mg (2 pump actuations) to each painful knee twice daily to clean, dry skin 5
  • Diclofenac topical solution reduces WOMAC pain scores by 4.5 points versus 3.6 points with placebo after 4 weeks 5
  • Apply 3-4 times daily for hand and knee osteoarthritis, with clinical effects evident within 2-4 weeks 1, 6
  • Approximately 60% of patients experience significant pain reduction over 6-12 weeks (NNT 9.8) 6

Ketoprofen Gel

  • Ketoprofen gel is the strongest alternative to diclofenac, with 63% of patients achieving significant pain relief versus 48% with placebo (NNT 6.9) over 6-12 weeks in chronic musculoskeletal pain 7, 6
  • For acute injuries, ketoprofen gel achieves 72% response versus 33% placebo at 7 days (NNT 2.5) 3, 4
  • Apply to affected areas 3-4 times daily 7

Critical Anatomical Limitation

Do NOT use topical NSAIDs for hip osteoarthritis due to inadequate drug penetration to the deep hip joint; oral NSAIDs are required instead 7

Second-Line Topical Agent

Capsaicin (Adjunct for Chronic Pain Only)

Capsaicin 0.025-0.075% cream is effective specifically for chronic osteoarthritis and neuropathic pain, NOT for acute injuries. 2, 8

Evidence-Based Indications

  • Hand osteoarthritis: EULAR guidelines recommend capsaicin with NNT of 3 for clinical improvement at 4 weeks 1, 2
  • Knee osteoarthritis: American College of Rheumatology conditionally recommends capsaicin for moderate knee pain 2
  • Contraindicated for hand OA per American College of Rheumatology due to risk of eye contamination, though EULAR guidelines support its use 2

Application Protocol

  • Apply 0.025-0.075% cream 3-4 times daily to affected areas 2, 7
  • Requires 2-4 weeks of continuous use before therapeutic effects occur, as capsaicin works by depleting substance P gradually 2, 8
  • Initial application causes burning sensation (affects 35-100% of patients), which peaks in week 1 and declines over time 9

Critical Pitfall to Avoid

Never use capsaicin for acute sprains or strains - its mechanism and evidence base are exclusively for chronic pain conditions lasting months to years, not acute injuries 8

Safety Profile Comparison

Topical NSAIDs

  • Local adverse events: Mild skin reactions occur in approximately 5% of patients versus 4% with placebo (NNH 51) 4
  • Systemic adverse events: No increase in gastrointestinal events compared to placebo (RR 0.81,95% CI 0.43 to 1.56) 1
  • Significantly safer than oral NSAIDs for GI bleeding risk (adjusted OR 1.45 vs 2.59 for oral NSAIDs) 1
  • In acute pain conditions, systemic or local adverse event rates (4.3%) are no greater than placebo (4.6%) 4

Capsaicin

  • Local burning sensation is the primary adverse event (NNH 2.6 for local reactions) 4
  • No systemic toxicity reported 9
  • Well-tolerated with continued use as burning sensation diminishes 9

Practical Treatment Algorithm

For Acute Musculoskeletal Injuries (Sprains, Strains)

  1. Start with topical diclofenac gel (Emulgel®) applied 3-4 times daily 3, 4
  2. Alternative: Ketoprofen gel 3-4 times daily if diclofenac unavailable 3, 4
  3. Do NOT use capsaicin for acute injuries 8

For Chronic Hand/Knee Osteoarthritis

  1. First-line: Topical diclofenac or ketoprofen gel 3-4 times daily 1, 7
  2. Add capsaicin 0.025-0.075% cream if topical NSAIDs insufficient after 2-4 weeks 2, 7
  3. Transition to oral NSAIDs at lowest effective dose if topical therapy inadequate after 6-8 weeks 1, 7

For Hip Osteoarthritis

Skip topical agents entirely and start with oral NSAIDs or acetaminophen as first-line pharmacotherapy due to inadequate penetration 7

Application Precautions

For Topical NSAIDs (Diclofenac)

  • Avoid showering/bathing for at least 30 minutes after application 5
  • Wait until treated area is completely dry before applying sunscreen, insect repellent, or other topical products 5
  • Avoid skin-to-skin contact with others until treated area is dry 5
  • Do not apply external heat or occlusive dressings to treated areas 5
  • Wash and dry hands after use 5

When Multiple Joints Are Affected

Systemic pharmacological treatment (oral NSAIDs) may be preferred over topical agents when a large number of joints are affected 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Role of Capsaicin Cream in Managing Osteoarthritis Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Topical NSAIDs for acute musculoskeletal pain in adults.

The Cochrane database of systematic reviews, 2015

Research

Topical NSAIDs for chronic musculoskeletal pain in adults.

The Cochrane database of systematic reviews, 2016

Guideline

Topical Alternatives to Diclofenac for Musculoskeletal Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Acute Musculoskeletal Injuries

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Capsaicin for osteoarthritis pain.

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.